EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Canals, Isaac ^a,b   Benetó, Noelia ^a,b   Cozar, Mónica ^a,b   Vilageliu, Lluïsa ^a,b   Grinberg, Daniel ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXTL2 PROTEIN, HUMAN; EXTL3 PROTEIN, HUMAN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; MEMBRANE PROTEIN; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; SMALL INTERFERING RNA;

FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MUCOPOLYSACCHARIDOSIS III; RNA INTERFERENCE;

FIBROBLASTS; GENE EXPRESSION; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MUCOPOLYSACCHARIDOSIS III; N-ACETYLGLUCOSAMINYLTRANSFERASES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84941124110     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13654     Document Type: Article

References (10)

1. Neufeld, E. F. & Muenzer, J. The Mucopolysaccharidoses in The metabolic and molecular bases of inherited disease (eds. Scriver, C. R. et al.) 3421-3452 (McGraw-Hill, 2001).
2. Sarrazin, S., Lamanna, W. C. & Esko, J. D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, 1-33 (2011).
3. Kreuger, J. & Kjellén, L. Heparan sulfate biosynthesis: regulation and variability. J. Histochem. Cytochem. 60, 898-907 (2012).
4. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
5. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
6. Dziedzic, D., Wegrzyn, G. & Jakóbkiewicz-Banecka, J. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. Eur. J. Hum. Genet. 18, 200-205 (2010).
7. Kaidonis, X. et al. Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses. Eur. J. Hum. Genet. 18, 194-199 (2010).
8. Canals, I. et al. Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles. Clin. Genet. 80, 367-374 (2011).
9. Barbosa, I. et al. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13, 647-653 (2003).
10. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).